Fig. 11From: Advanced imaging of colorectal cancer: From anatomy to molecular imaging 18F-FDG-PET for evaluating response to therapy. Changes secondary to therapy in a patient with rectal cancer treated with chemoradiation. Sagittal 18F-FDG-PET-CT image pretherapy (left) demonstrated an FDG-avid rectal mass (white arrow). Post-neoadjuvant chemoradiotherapy 18F-FDG-PET-CT image evidenced a complete tumour response (Courtesy JM Llamas- Elvira, MD. Department of Nuclear Medicine, Hospital Universitario Virgen de las Nieves, Granada, Spain)Back to article page